All lobbying filings
ZERO PROSTATE CANCER
Lobbying for ZERO PROSTATE CANCER · Prostate Cancer Non-Profit, Health and Wellness
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$123,567
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Virginia
Government bodies contacted
3
Lobbying activity
4
FY2026 Appropriations. Defense - Prostate Cancer Research Program; L-HHS - Prostate Cancer Activities, Division of Cancer Prevention and Control at the CDC, National Cancer Institute, National Institutes of Health, ARPA-H
HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans HR 7602 State of Mens Health Act - creating an Office of Men's Health at HHS
HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening
HR 5883 - POPCaP Authorization Act - VA Precision Oncology Program for Cancer of the Prostate